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ABSTRACT
An increased risk of late infection is a serious complication after allogeneic hematopoietic stem cell transplan-
tation (AHSCT), especially for recipients with defective CD4 T cell recovery. Although chronic graft-versus-
host disease (cGVHD) negatively influences CD4T cell reconstitution, the mechanisms leading to this defect
are not well understood. We found that the proportion of CD27 CD4 T cells was remarkably increased in
ASHCT recipients with cGVHD or with repetitive infectious episodes. Isolated CD27 CD4 T cells from
ASHCT recipients had significantly shortened telomere length, displayed enhanced vulnerability to activation-
induced cell death, and showed extremely reduced clonal diversity, when compared with CD27 CD4 T cells
from healthy donors. Also, CD27 CD4 T cells from AHSCT recipients easily lost their expression of CD27
in response to antigen stimulation regardless of cGVHD status. Taken together, these data indicate that
homeostasis of memory CD4 T cells from AHSCT recipients is altered, and that they easily transit into
CD27 effector memory T cells. Increased in vivo T cell stimulation observed in recipients with cGVHD
further promotes the transition to effector memory cells, a change that decreases the central memory CD4
T cell pool and consequently weakens the recipient’s defense against persistently infecting pathogens.
© 2007 American Society for Blood and Marrow Transplantation
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An increased risk of fatal infection remains the
ajor problem for long-term survivors of allogeneic
ematopoietic stem cell transplantation (AHSCT).
fter the immediate posttransplant period, AHSCT
ecipients experience long-lasting immune deﬁciency
1]. Several studies have demonstrated that quantita-
ive and qualitative recovery of CD4 T cells both
lay pivotal roles in protecting against late infections
nd in improving the long-term outcome of AHSCT
ecipients [2-4]. T cell reconstitution can involve both
thymus-dependent pathway and a thymus-indepen- c
176ent pathway. In the early posttransplant period, a
hymus-independent peripheral expansion of memory
cells occurs [5]. Because the reconstitution of the
D4 T cell pool is more dependent on thymic func-
ion [6], CD8 T cells predominate over CD4 T
ells for several months after AHSCT [5]. In the
etting of myeloablative autologous transplantation in
dults, it is reported that CD4 T cell regeneration
nd thymic enlargement occur by 6 months, and the
umber and diversity of naïve CD4 T cells normal-
zes 2 years after transplantation, at least in nonelderly
atients [7]. After AHSCT, reconstitution of CD4 T
ells is inﬂuenced not only by recipient age, but also
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Chronic GVHD Exhausts Central Memory CD4 T Cells 1177y sources of stem cells and, most important, by graft-
ersus-host disease (GVHD) [6,8-11].
Chronic GVHD (cGVHD) is a vexing late com-
lication that deeply inﬂuences the long-term out-
omes of AHSCT recipients. The disease develops in
bout 50% of AHSCT survivors, and for many is
esolved within 2 years following AHSCT [12-15].
nfortunately, some patients experience refractory
isease for an extended period, and their probability of
ong-term survival is lowered by opportunistic infec-
ion [12,16,17]. The presence of active cGVHD neg-
tively inﬂuence the recovery of CD4 T cells [11];
owever, how cGVHD impairs the functional recov-
ry of CD4 T cells is not yet well understood.
To clarify this mechanism, we analyzed the char-
cteristics of peripheral blood CD4 T cells in pa-
ients who received AHSCT at least 1 year earlier. We
lso aimed to establish reliable clinical indicators for
se in identifying AHSCT recipients for whom rein-
orced protection against late infection would be
ighly recommended.
ATIENTS, MATERIALS, AND METHODS
atients and Samples
Blood samples were obtained from 40 AHSCT
ecipients and 15 healthy donors after receiving their
ritten informed consents. AHSCT recipients had
ndergone transplantation 1 to 10 years prior. All
atients were conﬁrmed to be in complete donor chi-
erism and in complete remission. To exclude the
ffects on T cell characteristics derived from any con-
urrent infectious episodes, blood samples from fe-
rile patients were not drawn. The clinical character-
stics of AHSCT recipients are summarized in
able 1. The presence of cGVHD was deﬁned as
ollows: dependency on immunosuppressive agents in
atients who had received transplantation 3 years
efore, or the presence of active symptoms for which
mmunosuppressive therapy was required in patients
eceiving transplantations 1 to 3 years earlier. All
tudies using these blood samples were approved by
he Medical Ethics Committee of Kyoto University.
onoclonal Antibodies and Flow Cytometry
Mononuclear cells from the peripheral blood of
HSCT recipients or healthy donors (HDs) were
eparated by Ficoll-Paque Plus (Amersham Pharmacia
iotech, Piscataway, NJ) density gradient sedimenta-
ion. For analysis of cell surface antigens, cells were
ncubated with an appropriate concentration of ﬂuores-
ein isothiocyanate (FITC)-, phycoerythrin (PE)-, PE-
yanin-5 (PC5)-, or allophycocyanin (APC)-conjugated
onoclonal antibody (mAb) or the corresponding iso-
ype-matched control mAb (eBiosience, San Diego, CA)
n the dark at 4°C for 20 minutes. They were then iashed twice and analyzed by FACScalibur (BD Bio-
ciences, San Jose, CA) with CellQuest software (BD
iosciences). MAbs used in this study included FITC-
onjugated anti-CD27 (FITC-CD27), FITC-HLA-DR,
ITC-CD57, PE-CD27, PE-CCR7, FITC-CD62L,
PC- CD45RA (BD PharMingen, San Jose, CA), and
C5-CD4 (Beckman Coulter, Fullerton, CA). FITC-
nd PE-conjugated mAbs were purchased from eBio-
cience. For intracellular cytokine staining, cells were
uspended in culture medium consisting of RPMI 1640
Invitrogen, Carlsbad, CA), 10% volume fetal calf serum
FCS, Hyclone, Logan, UT), and antibiotics. They were
hen stimulated with immobilized anti-CD3 mAb
OKT3, 10 g/mL) and 2 g/mL soluble anti-CD28
Ab (clone48, agonistic antibody established in our
aboratory; T. Hori, unpublished data) for 5 hours in
he presence of 10 g/mL brefeldin A (BFA; Sigma-
ldrich, St. Louis, MO). After cell surface staining,
ells were ﬁxed with 2% formaldehyde (Wako Pure
hemical Industries, Osaka, Japan) diluted in phos-
hate-buffered saline (PBS), and permeabilized with
.2% saponin (Sigma-Aldrich) containing buffer.
fter washing with saponin-containing buffer, cells were
able 1. Characteristics of Patients, Donors, and Transplantations
Parameter Values*
ex of patients
Male/female 21/19
edian age of patients (range)
Patients 47 (20-70)
Donors** 41 (20-63)
onor type
MSD/Non-MSD 15/25
tem cell source
Bone marrow 28
Peripheral blood 10
Cord blood 2
iagnosis
Acute leukemia 9
Chronic myeloproliferative disease 8
Lymphoma or myeloma 13
Myelodysplastic syndrome 5
Aplastic Anemia 4
Adrenoleukodystrophy 1
onditioning regimen
Myeloablative 25
Reduced intensity 15
VHD prophylaxis
Cyclosporine-based 9
Tacrolimus-based 31
nterval after AHSCT
1 to 3 years 18
3 to 5 years 15
more than 5 years 7
SD indicates matched sibling donor; GVHD, graft-versus-
host disease; AHSCT, allogeneic hematopoietic stem cell
transplantation.
Values are expressed as number of patients otherwise indicated.
*Cord blood donor is excluded.ncubated with FITC-conjugated anti-interferon-
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A. Fukunaga et al.1178IFN-), FITC-conjugated anti-interleukin-2 (IL-2),
r FITC-conjugated isotype-matched control mAb.
ll mAbs used for cytokine staining were obtained
rom BD PharMingen.
D4 T Cell Separation and Cell Sorting
CD4 T cells were isolated by a MACS CD4 mul-
isort kit (Miltenyi Biotec, Bergisch Gladbach, Ger-
any), using MACS separation MS columns (Miltenyi
iotec) according to the manufacturer’s recommenda-
ions. They were then stained with PE-CD27 and APC-
D45RA and sorted into naïve (CD27/CD45RA),
D27 memory (CD27/CD45RA), and CD27
emory cells using FACSAria (BD Biosciences) with
ACSDiVa 4.1 software (BD Biosciences). In some ex-
eriments, CD4 T cells from AHSCT recipients were
tained with PE-CD27 only and sorted into CD27 and
D27 cells. Sorted T cell subsets displayed a purity of
t least 98%.
Cell Stimulation and Short-Term Culture
Isolated naïve, CD27 memory, and CD27
emory T cells were suspended in a culture medium
t a concentration of 5  105/mL, and 1 mL of cell
uspension was transferred into a 48-well plate coated
ith anti-CD3 mAb. The concentration of anti-CD3
Ab was either high (10 g/mL) or low (0.1 g/mL).
nti-CD28 mAb (2 g/mL) was also added to the
ulture. T cell stimulation with anti-CD3 and anti-
D28 mAbs (CD3/28 stimulation) was performed for
days; the cells were then harvested, washed twice,
nd incubated with culture medium supplemented
ith 150 IU/mL IL-2 (Peprotec, Rocky Hill, NJ) at a
oncentration of 2  105/mL for an additional 4 days.
n some experiments, after 7-day cultivation, the cells
ere harvested, washed, prepared at a concentration
f 5  105/mL in culture medium, and restimulated
vernight on an anti-CD3 mAb-coated plate (10g/
L). T cell death was determined by propidium io-
ide (PI, Sigma-Aldrich) staining in which a ﬁnal
oncentration of 1 g/mL of PI was added to each cell
ample before ﬂow cytometry analysis.
low-FISH
Relative telomere length (RTL) measurements of
D27 memory and CD27 memory CD4 T cells
ere performed by a ﬂow-FISH method using a Dako
elomere peptide nucleic acid (PNA) kit/FITC
Dako, Glostrup, Denmark), according to the manu-
acturer’s instructions. In brief, isolated cells and con-
rol cells (1301 cell line; Interlab Cell Line Collection,
enoa, Italy) were mixed in equal measure in hybridiza-
ion solution with or without FITC-labeled telomere
NA probe for 10 minutes at 82°C; hybridized over-
ight in the dark at room temperature; washed twice
ith a wash solution at 40°C; resuspended in PBS tontaining 2% FCS and PI (1 g/mL); and subjected
o ﬂow cytometric analysis. Telomere ﬂuorescence of
t least 100,000 events was measured at a low ﬂow rate
o ensure low coefﬁcients of variation. The RTL value
as calculated using the following formula: RTL 
[mean FL1 sample cells with probe  mean FL1
ample cells without probe]  DNA index of control
ells)  ([mean FL1 control cells with probe  mean
L1 control cells without probe]  DNA index of
ample cells) 100. Because 1301 is a tetraploid cell line,
he DNA index of 1301 cells is 2 and the DNA index of
ample cells in this study is 1.
Cell Receptor Repertoire Analysis and
omplementarity-Determining Region 3
ize Spectratyping
RNA isolated from naïve, CD27 memory, and
D27 memory cells was converted to double-
tranded complementary DNA (cDNA), and T cell
eceptor (TCR) beta chain variable region (VB) rep-
rtoires were analyzed with an adaptor ligation poly-
erase chain reaction (PCR)-based microplate hy-
ridization assay [18]. After PCR ampliﬁcations using
rimers speciﬁc for each TCRVB, the 5=-biotinylated
CR products were hybridized in microplate wells on
hich 38 TCRVB-speciﬁc probes were immobilized,
nd followed with quantitative ELISA. PCR products
ere also subjected to analysis for complementary-
etermining region 3 (CDR3) size spectratyping [19];
hey were diluted in dye solution (95% formamide, 10
M EDTA, and 0.1% blue dextrane) and analyzed in
% denatured acrylamide gel with an ALFred se-
uence analyzer (Pharmacia Biotech, Uppsala, Swe-
en). The data obtained were transferred to Fragment
anager software (Pharmacia Biotech).
tatistical Analysis
We used a 2-sided Mann-Whitney U test (non-
aired samples) and a paired t-test (paired samples) for
n analysis of differences between the groups. P values
.05 were considered statistically signiﬁcant.
ESULTS
he Proportion of CD27 CD4 T Cells Increased
n AHSCT Recipients, Especially in Those with
GVHD
During comparative analysis of peripheral CD4
cells from AHSCT recipients and HDs, we found
hat the proportion of CD27 cells among total
D4 T cells was substantially higher in AHSCT
ecipients who had been transplanted more than 1
ear previously. As shown in Figure 1A, identiﬁed 3
ajor subsets of CD4 T cells by dual staining, using
D45RA and CD27. The CD45RA/CD27 frac-ion represents naïve T cells, and the CD27 fraction
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Chronic GVHD Exhausts Central Memory CD4 T Cells 1179s known to include terminally differentiated cells [20].
he CD45RA/CD27 fraction is composed of cen-
ral memory T cells [21]. When data from 19 AHSCT
ecipients (interval after AHSCT ranged from 1.5 to
0 years, median 4 years) and 15 HDs were compared,
t was clear that the percentage of naïve T cells was
ow, and that of CD27 memory cells was substan-
ially high within the CD4 T cell subset from
HSCT recipients (Figure 1B-D). To search for a
orrelation between the percentage of CD27 cells
mong total CD4T cells and the clinical parameters,
amples from an additional 21 patients who had re-
eived AHSCT more than 1 year before were col-
ected. Statistical analysis revealed 2 variables associ-
ted with the increased proportion of the CD27
raction: the presence of cGVHD and a poor general
ondition, deﬁned by a Karnofsky score of less than 90
Figure 1E). An analysis of clinical charts demon-
igure 1. Proportion of CD27 cells among total CD4 T cells in
HSCT recipients and healthy donors. Peripheral lymphocytes
rom AHSCT recipients and HDs were stained with CD4, CD27,
nd CD45RA and gates were set on CD4-positive lymphocytes. A,
epresentative dot plots of CD45RA and CD27 are shown. The
ercentage of CD27 CD45RA naïve, CD27 CD45RA mem-
ry, and CD27 memory cells are shown in the upper right of each
lot. The percentage of naïve (B), CD27memory (C), and CD27
emory cells (D) among total CD4T cells was compared between
6 AHSCT recipients and 15 HDs. E, Comparison of the percent-
ge of CD27 memory cells among total CD4 T cells between
HSCT recipients in the presence or absence of cGVHD (left), and
ith or without good physical condition (right). Samples from 40
HSCT recipients were included. The median, 25th-75th percen-
iles, 10th-90th percentiles, and outliers are represented by the
ine in the box, shaded box, error bars, and open circles, respec-
ively. A Mann-Whitney U test was used for statistical analysis.trated that repetitive infectious episodes reduced the weneral condition of most patients, and many of them
but not all) also suffered from cGVHD (data not
hown). The frequency of CD27 cells among CD4
cells did not correlate with recipient age, source of
tem cells, donor type, underlying disease, condition-
ng regimen, history of acute GVHD (aGVHD), or
nterval after transplantation (data not shown). Al-
hough van Leeuwen reported that individuals who
ere persistently infected with cytomegalovirus
CMV) showed increased frequency of CD27
D28 cells within CD4 T cells [22], in our exper-
ments, no pair of AHSCT recipient and donor was
ound to be serologically negative for CMV at the
ime of SCT; thus, we could not evaluate the corre-
ation between persistent CMV infection and the pro-
ortion of CD27 cells.
We then analyzed surface phenotype and cytokine
roﬁles of CD27 CD4 T cells from AHSCT recipi-
nts. Multicolor ﬂow cytometry revealed that CD27
D4 T cells preferentially expressed HLA-DR and
D57 and expressed very little CCR7 or CD62L (data
ot shown). Cytokine proﬁles of CD27 CD4 T cells
ere determined by sorting CD4 T cells into CD27
nd CD27 fractions. CD3/28 stimulation followed by
ntracytoplasmic cytokine-staining revealed that CD27
ells produced IFN- much more frequently than
D27 cells, and the proportion of IL-2-producing
ells was comparable (data not shown). The expression
f surface molecules and cytokine-producing capacity
howed no signiﬁcant difference between CD27
D4 T cells from AHSCT recipients and HDs (data
ot shown). These results are consistent with previous
tudies and demonstrating that CD27 CD4 T cells
re differentiated effector cells [21,23].
hortened Telomere Length and Enhanced
ulnerability to Activation-Induced Cell Death of
D27 CD4 T Cells from AHSCT Recipients
To better understand the differentiated status of
D27 cells in AHSCT recipients, we examined and
ompared the telomere length of sorted CD4 T cell
ractions derived from AHSCT recipients and HDs.
D4 T cells from HDs were sorted into naïve,
D27 memory, and CD27 memory cells as shown
n Figure 2A. In CD4 T cells from AHSCT recipi-
nts, naïve cells were not separated from CD27
emory cells because of the limited total cell number
vailable and the scarcity of naïve cells. Figure 2B
hows representative dot plots for the measurements
f relative telomere lengths (RTLs) of sample cells,
sing the ﬂow-FISH method. The RTL of CD27
ells was shorter when compared with those of
D27 cells in AHSCT recipients and HDs (Figure
C). Most important, CD27 cells from AHSCT re-
ipients showed signiﬁcantly shorter RTLs compared
ith those from HDs (Figure 2C). Because previous
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A. Fukunaga et al.1180ork demonstrated that telomere length shortens in
he course of T cell differentiation [24], these results
ndicated that CD27 CD4 T cells from AHSCT
ecipients undergo more cell divisions and are more
ifferentiated than those from HDs.
We next evaluated the vulnerability to activation-
nduced cell death (AICD), because differentiated T
ells are known to be susceptible to apoptosis [25].
orted CD27 and CD27 CD4 T cells from 8
HSCT recipients (4 of them complaining of
GVHD) and CD27 and CD27 memory CD4 T
ells from 9 HDs were subjected to CD3/28 stimula-
ion, cultivation with IL-2, and restimulation with
nti-CD3 mAb [26]. As expected in every patient and
ealthy donor, CD27 CD4 T cells were more sus-
eptible to IL-2-induced AICD after a second stimula-
ion than were CD27CD4T cells (Figure 3A and B).
n accordance with a shorter telomere length, CD27
D4 T cells from AHSCT recipients showed more
ell deaths than those from HDs. CD27 CD4 T
ells from AHSCT recipients showed comparable vul-
erability to AICD whether from patients with or
igure 2. Shortened telomere length in CD27 CD4 T cells.
agnetically isolated, peripheral blood CD4 T cells from
HSCT recipients were stained with CD27 and sorted into CD27
nd CD27 cells. CD4 T cells from HDs were stained with CD27
nd CD45RA and sorted into CD27memory and CD27memory
cells. A, Representative dot plots of HD-derived CD4 T cells
efore and after cell sorting are shown. B, Sorted T cells were
ndividually mixed in equal measure with control cell line 1301,
ybridized with or without an FITC-labeled PNA-telomere probe,
ounterstained with PI, and analyzed by FACScalibur. The percent
TL (relative telomere length) was calculated as described in the
atients, Materials, and Methods section. C, The percent of RTL in
D27 and CD27 cells from 6 AHSCT recipients and in CD27
emory and CD27 memory cells from 6 HDs were analyzed by
ow-FISH. Statistical analysis was performed using a paired t-test
*) and Mann-Whitney U test (**).ithout cGVHD (Figure 3B). tubstantially Reduced T Cell Repertoire Diversity
f CD27 CD4 T Cells from AHSCT Recipients
For effective immunity against various pathogens,
road T cell repertoire diversity is essential [27]. Re-
orted experiments using total lymphocytes or sorted
D4 T cells have shown that skewing of T cell
epertoire after stem cell transplantation continues for
n extended period [28,29]. To better understand im-
unologic reconstitution after AHSCT, sorted naïve,
D27 memory, and CD27 memory CD4 T cells
ere individually subjected to microplate hybridiza-
ion assay to determine TCRVB repertoires, and per-
orm CDR3 spectratyping. As shown in Figure 4, we
ound that naïve cells and CD27 memory cells from
HSCT recipients showed diverse CDR3 size spec-
ratypes with a Gaussian distribution of TCR frag-
ents, identical to those from HDs [30]. In con-
rast, the TCRVB repertoire of CD27 memory
D4 T cells was prominently skewed, and CDR3
ize spectratypes were characterized by oligoclonal
xpansions, which was much more prominent in
HSCT recipients.
igure 3. IL-2-induced AICD assay of CD4 T cells from AHSCT
ecipients and HDs. Isolated CD4T cells from AHSCT recipients
ere sorted into CD27 and CD27 T cells. Memory CD4 T
ells from HDs were sorted into CD27 memory, and CD27
emory cells. Sorted cells were stimulated with 0.1 g/mL plate-
ound anti-CD3 mAb and 2 g/mL soluble anti-CD28 mAb for 3
ays. Cells were then cultured with IL-2 for another 4 days and
estimulated with 10 g/mL plate bound anti-CD3 mAb overnight.
he collected cells were stained with PI and the ratio of PI-positive
ells was analyzed by ﬂow cytometry. A, Representative histogram
f PI staining. Values shown denote the percentage of nonviable
ells. B, The vulnerability to IL-2-induced AICD was compared
etween CD27 and CD27 cells from 8 AHSCT recipients and 9
Ds (left). A comparison of the ratio of PI-positive cells among
D27 T cells from AHSCT recipients with or without cGVHD is
hown (right). Statistical analysis was performed using a paired
-test (*) and a Mann-Whitney U test (**).
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Chronic GVHD Exhausts Central Memory CD4 T Cells 1181D27 CD4 T Cells from AHSCT Recipients
asily Lost CD27 Molecules
We next investigated the mechanism by which the
ercentage of peripheral CD27 CD4 T cells in-
reases in AHSCT recipients. We hypothesized that
ransition of CD27 memory T cells into CD27
ells was accelerated to cause this effect. As shown
reviously, CD27 memory cells are composed of
CR7 “central memory” and CCR7 “effector
emory” subpopulations [21,31]. We found that the
requency of CCR7 cells in CD27 memory cells
as similar between AHSCT recipients and HDs
data not shown), indicating that CD27 memory
ells from AHSCT recipients were, as a whole, not
igniﬁcantly different in differentiation than those
rom HDs. The kinetics of CD27 expression in re-
ponse to CD3/28 stimulation was examined with
orted CD27 CD4 T cells. Naïve cells from HDs
howed negligible loss of CD27 expression upon stim-
lation in either strong (plate-bound OKT3 at 10
g/mL) or weak (0.1 g/mL) conditions. Strong but
ot weak stimulation conditions decreased the per-
entage of CD27 cells in CD27 memory T cells
rom those of HDs. In contrast, CD27 cells from
HSCT recipients, which included a minor popu-
ation of naïve cells, remarkably lost their CD27
xpression upon both strong and weak stimulation
Figure 5A). The presence or absence of cGVHD
id not affect the extent of downregulation of CD27
xpression.
ISCUSSION
Recent studies indicate that CD4 memory T
ells can be divided into distinct populations of central
igure 4. TCR repertoire analysis of sorted CD4 T cells. RNA wa
cells from AHSCT recipients as well as from HDs. TCR repe
escribed in the Patients, Materials, and Methods section. Because t
n most individuals examined, CDR3 spectratypes of these TCR
ndividual TCRVBs among a sorted population deﬁned by microplat
ecipients.emory and effector memory cells according to their fCR7 expression proﬁles [31]. Further, Fritsch pro-
osed that effector memory T cells that lose expres-
ion of CD27 form a subpopulation of terminally
ifferentiated memory cells [21]. In fact, prolonged
timulation of CD27 memory CD4 T cells was
hown to result in irreversible loss of CD27 expression
n vitro and in vivo [32,33]. CD27 CD4 T cells are
nriched in inﬂamed peripheral tissues, such as the
ucosal lamina propria of inﬂammatory bowel disease
atients [34] or synovial tissues of rheumatoid arthritis
atients [35]. The increase in CD27 memory cell
requency among peripheral total blood CD4 T cells
as been demonstrated in patients with systemic lupus
rythematosus [36] and in healthy elderly individuals
37], and the increase in the ratio of CD27 cells is
ssumed to be the consequence of either enhanced T
ell differentiation induced by repetitive in vivo T cell
timulation [35,36] or of increased peripheral homeo-
tatic expansion because of reduced thymic output
37,38].
In this study, we showed that the proportion of
D27 cells among total CD4 T cells, which is
10% in nonelderly healthy adults [20,39] and about
5% in patients with SLE [36] or in elderly individuals
37] was substantially increased for extended periods
up to 10 years) in AHSCT recipients (median
9.5%); it was especially high in patients with
GVHD (median 44.5%) or impaired general condi-
ions resulting from repetitive infectious episodes
median 53.5%). Fallen and colleagues [40] also re-
orted an increase in the number of CD27 CD4 T
ells for patients within the ﬁrst year after AHSCT
hen thymic function was not sufﬁciently recovered
9]. The CDR3 spectratypes of naïve and CD27
emory CD4 T cells clearly show that the thymic
d from sorted naïve, CD27 memory, and CD27 memory CD4
nalysis, followed by CDR3 size spectratyping, was performed as
uency of TCRVB 2-1, 4-1, 6-4, 8-1, 13-1, and 17-1 was dominated
e shown. Values in each spectratype represent the frequency of
dazation assay. The data are representative of 3 HDs and 5 AHSCTs isolate
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A. Fukunaga et al.1182efore is sufﬁcient to maintain a T cell repertoire with
ormal diversity in terms of TCRVB usage; therefore,
educed thymic output does not fully explain the ex-
remely elevated proportion of CD27 cells in AH-
CT recipients.
In accordance with previous reports [21,23,35] we
onﬁrmed that CD27 CD4 T cells displayed more
ifferentiation than CD27 memory cells. In addi-
ion, recent reports indicate that expression of CD57,
hich was more frequently detected on CD27
D4 T cells in our study, correlates with replicative
enescence [41,42]. Moreover, CD27 memory cells
rom AHSCT recipients showed greater reduction in
elomere length and increased vulnerability to AICD
han those from HDs. Several studies demonstrated
hat telomere length is useful in assessing the extent of
ifferentiation in lymphocyte populations, and that T
ells with shorter telomeres are accompanied by re-
uced telomerase induction, a diminished replicative
apacity following activation, and an increased suscep-
ibility to apoptosis [24,38]. The substantially reduced
igure 5. Kinetics of surface CD27 expression after CD3/28 stim-
lation. CD27 CD4 T cells obtained by cell sorting from AH-
CT recipients, and naïve and CD27 memory CD4 T cells were
solated from HDs. The cells received CD3/28 stimulation for 3
ays, followed by cultivation with IL-2 for 4 days. A, The cells were
ollected on days 3, 5, and 7, stained with FITC-CD27, and ana-
yzed for CD27 expression with ﬂow cytometry. The solid line and
otted line represents naïve cells, and CD27 memory T cells from
Ds, respectively (N  5). Fine dotted line indicates CD27 cells
rom AHSCT recipients (N  4). In CD3/28 stimulation, weak
plate-bound anti-CD3 mAb, 0.1 g/mL) and strong (10 g/mL)
onditions were utilized. B, (Left) The percentage of CD27-positive
ells after a 7-day cultivation. CD27 cells from 9 AHSCT recip-
ents and CD27 memory cells from 5 HDs were stimulated under
eak conditions. (Right) Comparison of day 7 expression of CD27
etween AHSCT recipients with or without cGVHD. Analysis was
erformed using the Mann-Whitney U test.cell repertoire diversity of CD27 cells from sHSCT recipients also supports the notion that these
ells experience repetitive stimulation in vivo, result-
ng in a more prominent clonal expansion than the
ame cells in HDs. Because the proportion of CD27
ells greatly increases in patients with cGVHD, a
ajor proportion of circulating CD4 T cells are
erived from oligoclonal expansion of CD27 cells
ith reduced proliferative potentials.
CD27 CD4 T cells are cells involved in the
rst-line defense against pathogens. The combinato-
ial expression of adhesion molecules and chemokine
eceptors on CD27 CD4 T cells facilitates their
mmediate distribution into inﬂamed peripheral tis-
ues, where they promptly produce effector cytokines
nd deliver direct cytotoxic effects [33,39,43]. Casazza
t al. [33] reported that antigen-speciﬁc CD4T cells,
uch as CMV-speciﬁc T cells, are abundant in this
opulation. However, the signiﬁcance of effector
emory T cells in long-term immune control has
ecently become questionable. Heller et al. [44] dem-
nstrated that protective immune control for persis-
ently infecting pathogens require a reservoir of cen-
ral memory T cells that continuously fuels effector
emory cells. In addition, Fletcher et al. [45] reported
hat a large amount of CMV-speciﬁc T cells with a
ate differentiated phenotype (CD27, CD28) does
ot always contribute to effective immunity against
MV, because such cells showed severely restricted
eplicative capacity. An appropriate proportional bal-
nce between central memory and effector memory
ells, between CD27 memory and CD27 memory
D4 T cells, is requisite for effective long-term
ontrol against persistently infecting pathogens, such
s CMV.
We found that the ratio of CD27 cells signiﬁ-
antly increases after delivery of CD3/28 stimulation
o CD27 cells from AHSCT recipients when com-
ared to those from HDs. As the condition of
GVHD did not affect the degree of downregulation,
e suggest that CD27 cells from AHSCT recipients
ave an intrinsic tendency to easily differentiate into
ffector memory cells. Poulin et al. [10] demonstrated
hat the survival of naïve T cells in AHSCT recipients
s shortened even in the absence of cGVHD. Our data
uggested that the homeostasis of CD27 memory T
ells is also altered in AHSCT recipients. In patients
ith cGVHD, sustained delivery of alloantigenic
timuli is presumed to drive alloreactive CD27
emory T cells to differentiate into CD27 cells. In
ddition, immune reaction associated with cGVHD
ould also promote the differentiation of nonhost-
eactive CD27 memory T cells in a bystander fash-
on [45,46]. As an explanation for the correlation be-
ween increased frequency of CD27 CD4 T cells
nd repetitive infectious episodes, we posit the follow-
ng rationale. In the course of infectious episodes,
igniﬁcant amount of CD27 central memory CD4
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Chronic GVHD Exhausts Central Memory CD4 T Cells 1183cells receive differentiation-inducing stimuli in both
n antigen-speciﬁc and bystander fashion. Because
HSCT recipients are at high risk of developing in-
ections, especially when continuous use of corticoste-
oids is required, they have higher probability of suf-
ering more than 1 infectious episode. As central
emory T cells of AHSCT recipients easily differen-
iate into effector memory cells, repeated infections
asten the differentiation of CD27 memory cells,
eaving the central memory T cell pool diminished. As
result, AHSCT recipients become more susceptible
o opportunistic infections, and the CD27 memory
cell pool becomes exhausted.
Taken together, we propose a hypothesis for the
efective immunity observed in AHSCT recipients:
n vivo T cell stimulation in AHSCT recipients with
GVHD or repetitive infectious episodes pro-
oundly promotes the differentiation of CD27
emory CD4 T cells; as a result, the CD27
emory cell pool decreases, which makes continu-
us control against persistently infecting pathogens
ifﬁcult. We also propose that the ratio of CD27
ells among total CD4 T cells could serve as an
ffective clinical indicator, identifying patients who
ay likely require a more intensive regimen for
rotection against opportunistic infections.
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